新型冠状病毒感染或疫苗诱发的新发格雷夫斯病病例报告？
A case report of new onset graves' disease induced by SARS-CoV-2 infection or vaccine?
作者信息
Hamouche Walid, El Soufi Yahya, Alzaraq Saleh, Okafor Belonwu Valentine, Zhang Fan, Paras Christos
机构信息
Internal Medicine Department, Brookdale University Hospital Medical Center, 1 Brookdale Plaza, Brooklyn, NY, USA.
Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon.
出版信息
J Clin Transl Endocrinol Case Rep. 2022 Mar;23:100104. doi: 10.1016/j.jecr.2021.100104. Epub 2021 Dec 17.
Abstract
The virus responsible for the COVID-19 pandemic continues to pose unmatched challenges in the world. It can cause systemic inflammation, which can lead to multiorgan involvement and subsequent damage. The relationship that possibly exists between the COVID-19 infection, the newly developed vaccines, and thyroid disease are still under extensive investigation. We are reporting the first case of new-onset graves' disease in a young, healthy man after COVID-19 infection and receiving a COVID-19 vaccine dose.
摘要
导致新冠疫情的病毒继续在全球造成前所未有的挑战。它可引发全身炎症，进而导致多器官受累及后续损害。新冠感染、新研发的疫苗与甲状腺疾病之间可能存在的关系仍在广泛研究中。我们报告了首例在新冠感染并接种一剂新冠疫苗后，一名年轻健康男性新发格雷夫斯病的病例。
相似文献
1
A case report of new onset graves' disease induced by SARS-CoV-2 infection or vaccine?新型冠状病毒感染或疫苗诱发的新发格雷夫斯病病例报告？
J Clin Transl Endocrinol Case Rep. 2022 Mar;23:100104. doi: 10.1016/j.jecr.2021.100104. Epub 2021 Dec 17.
2
Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report and Literature Review.接种 SARS-CoV-2 mRNA 疫苗后 Graves 病的发病：病例报告及文献复习。
Front Public Health. 2021 Nov 23;9:778964. doi: 10.3389/fpubh.2021.778964. eCollection 2021.
3
Thyrotoxicosis in patients with a history of Graves' disease after SARS-CoV-2 vaccination (adenovirus vector vaccine): Two case reports.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗（腺病毒载体疫苗）接种后有格雷夫斯病病史患者的甲状腺毒症：两例病例报告。
World J Clin Cases. 2023 Feb 16;11(5):1122-1128. doi: 10.12998/wjcc.v11.i5.1122.
4
Thyroid Eye Disease as Initial Manifestation of Graves' Disease Following Viral Vector SARS-CoV-2 Vaccine: Report of a Case and Review of the Literature.甲状腺眼病作为病毒载体 SARS-CoV-2 疫苗接种后格雷夫斯病的初始表现：一例报告及文献复习
Vaccines (Basel). 2023 Oct 10;11(10):1574. doi: 10.3390/vaccines11101574.
5
SARS-CoV-2 plays a pivotal role in inducing hyperthyroidism of Graves' disease.SARS-CoV-2 在诱发格雷夫斯病的甲状腺功能亢进中起关键作用。
Endocrine. 2021 Aug;73(2):243-254. doi: 10.1007/s12020-021-02770-6. Epub 2021 Jun 9.
6
Graves' disease following administration of second dose of SARS-CoV-2 vaccine.接种第二剂 SARS-CoV-2 疫苗后发生 Graves 病。
BMJ Case Rep. 2021 Dec 30;14(12):e246432. doi: 10.1136/bcr-2021-246432.
7
New-onset Graves' disease following SARS-CoV-2 vaccination: a case report.新型冠状病毒疫苗接种后新发格雷夫斯病：一例报告
Eur Thyroid J. 2022 Jul 19;11(4). doi: 10.1530/ETJ-22-0049. Print 2022 Aug 1.
8
Graves' disease post-COVID-19 m-RNA vaccine in pediatric age group.儿童年龄组中新冠mRNA疫苗接种后出现的格雷夫斯病
Asia Ocean J Nucl Med Biol. 2024;12(1):65-68. doi: 10.22038/AOJNMB.2023.73051.1510.
9
Graves Disease Following the SARS-CoV-2 Vaccine: Case Series.接种新冠病毒疫苗后发生 Graves 病：病例系列。
J Investig Med High Impact Case Rep. 2021 Jan-Dec;9:23247096211063356. doi: 10.1177/23247096211063356.
10
Occurrence of Graves' Orbitopathy and Graves' Hyperthyroidism after a Trauma to the Eye.眼部外伤后格雷夫斯眼眶病和格雷夫斯甲状腺功能亢进症的发生
Eur Thyroid J. 2018 Jan;7(1):51-54. doi: 10.1159/000479629. Epub 2017 Aug 22.
引用本文的文献
1
SARS-CoV-2-Vaccine-Related Endocrine Disorders: An Updated Narrative Review.严重急性呼吸综合征冠状病毒2型疫苗相关内分泌疾病：最新叙述性综述
Vaccines (Basel). 2024 Jul 8;12(7):750. doi: 10.3390/vaccines12070750.
2
Graves' disease post-COVID-19 m-RNA vaccine in pediatric age group.儿童年龄组中新冠mRNA疫苗接种后出现的格雷夫斯病
Asia Ocean J Nucl Med Biol. 2024;12(1):65-68. doi: 10.22038/AOJNMB.2023.73051.1510.
3
Graves' disease after exposure to the SARS-CoV-2 vaccine: a case report and review of the literature.接种 SARS-CoV-2 疫苗后发生 Graves 病：病例报告及文献复习。
BMC Endocr Disord. 2023 Jun 15;23(1):132. doi: 10.1186/s12902-023-01387-2.
4
New-onset Thyroid Eye Disease after COVID-19 Vaccination in a Radioactive Iodine-Treated Graves' Disease Patient: A Case Report and Literature Review.COVID-19 疫苗接种后放射性碘治疗 Graves 病患者新发甲状腺眼病：病例报告及文献复习。
J ASEAN Fed Endocr Soc. 2023;38(1):125-130. doi: 10.15605/jafes.038.01.19. Epub 2023 Feb 8.
5
Graves' disease following vaccination against SARS-CoV-2: A systematic review of the reported cases.接种 SARS-CoV-2 疫苗后发生格雷夫斯病：已报告病例的系统回顾。
Front Endocrinol (Lausanne). 2022 Sep 27;13:938001. doi: 10.3389/fendo.2022.938001. eCollection 2022.
6
Graves' Disease Following SARS-CoV-2 Vaccination: A Systematic Review.新冠病毒疫苗接种后发生的格雷夫斯病：一项系统综述
Vaccines (Basel). 2022 Sep 1;10(9):1445. doi: 10.3390/vaccines10091445.
7
Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.接种 COVID-19 疫苗后的自身免疫和自身炎症性疾病。新病例报告和最新文献回顾。
J Autoimmun. 2022 Oct;132:102898. doi: 10.1016/j.jaut.2022.102898. Epub 2022 Aug 24.
8
Thyroid Inconveniences With Vaccination Against SARS-CoV-2: The Size of the Matter. A Systematic Review.甲状腺与接种 SARS-CoV-2 疫苗的不适反应：问题的大小。系统综述。
Front Endocrinol (Lausanne). 2022 Jun 23;13:900964. doi: 10.3389/fendo.2022.900964. eCollection 2022.
9
Autoimmune and inflammatory thyroid diseases following vaccination with SARS-CoV-2 vaccines: from etiopathogenesis to clinical management.自身免疫和炎症性甲状腺疾病与 SARS-CoV-2 疫苗接种相关：从发病机制到临床管理。
Endocrine. 2022 Dec;78(3):406-417. doi: 10.1007/s12020-022-03118-4. Epub 2022 Jun 28.
10
Orbital inflammatory disease following mRNA SARS-CoV-2 vaccine.新型冠状病毒mRNA疫苗接种后的眼眶炎性疾病
Clin Case Rep. 2022 Jun 7;10(6):e05926. doi: 10.1002/ccr3.5926. eCollection 2022 Jun.
本文引用的文献
1
Thyroid disease and covid-19 infection: Case series.甲状腺疾病与新冠病毒感染：病例系列
Clin Case Rep. 2021 Jun 17;9(6):e04225. doi: 10.1002/ccr3.4225. eCollection 2021 Jun.
2
SARS-CoV-2 plays a pivotal role in inducing hyperthyroidism of Graves' disease.SARS-CoV-2 在诱发格雷夫斯病的甲状腺功能亢进中起关键作用。
Endocrine. 2021 Aug;73(2):243-254. doi: 10.1007/s12020-021-02770-6. Epub 2021 Jun 9.
3
COVID-19: vaccine's progress.COVID-19：疫苗的进展。
Microb Biotechnol. 2021 Jul;14(4):1246-1257. doi: 10.1111/1751-7915.13818. Epub 2021 May 7.
4
Two Cases of Graves' Disease Following SARS-CoV-2 Vaccination: An Autoimmune/Inflammatory Syndrome Induced by Adjuvants.两例接种 SARS-CoV-2 疫苗后发生的 Graves 病：佐剂诱导的自身免疫/炎症综合征。
Thyroid. 2021 Sep;31(9):1436-1439. doi: 10.1089/thy.2021.0142. Epub 2021 May 3.
5
The SARS-CoV-2 as an instrumental trigger of autoimmunity.SARS-CoV-2 作为自身免疫的工具性触发因素。
Autoimmun Rev. 2021 Apr;20(4):102792. doi: 10.1016/j.autrev.2021.102792. Epub 2021 Feb 19.
6
Endocrine Involvement in COVID-19: Mechanisms, Clinical Features, and Implications for Care.新型冠状病毒肺炎中的内分泌系统受累：机制、临床特征及对治疗的意义
Indian J Endocrinol Metab. 2020 Sep-Oct;24(5):381-386. doi: 10.4103/ijem.IJEM_440_20. Epub 2020 Nov 9.
7
Thyroid Dysfunction in Relation to Immune Profile, Disease Status, and Outcome in 191 Patients with COVID-19.191 例 COVID-19 患者的甲状腺功能障碍与免疫谱、疾病状况和预后的关系。
J Clin Endocrinol Metab. 2021 Jan 23;106(2):e926-e935. doi: 10.1210/clinem/dgaa813.
8
SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves' disease after COVID-19.严重急性呼吸综合征冠状病毒2引发自身免疫性疾病：两例新冠病毒感染后格雷夫斯病病例报告
J Endocrinol Invest. 2020 Oct;43(10):1527-1528. doi: 10.1007/s40618-020-01366-7. Epub 2020 Jul 19.
9
A case of subacute thyroiditis associated with Covid-19 infection.一例与新型冠状病毒肺炎感染相关的亚急性甲状腺炎病例。
J Endocrinol Invest. 2020 Aug;43(8):1173-1174. doi: 10.1007/s40618-020-01316-3. Epub 2020 Jun 5.
10
SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case report.严重急性呼吸综合征冠状病毒2：亚急性甲状腺炎的潜在诱因？ 一项病例报告的见解
J Endocrinol Invest. 2020 Aug;43(8):1171-1172. doi: 10.1007/s40618-020-01312-7. Epub 2020 Jun 2.
Zotero 插件